Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...

Pharmacy spend will rise 3.8%, driven in part by increased demand for specialty medications. AbbVie’s autoimmune disease drug Humira will continue to be the most popular drug by total spend, however ...

and that shift is reflected in the list of the top 15 drugs by total spend for Vizient pharmacy program participants. Humira®, manufactured by AbbVie, is again at the top of the list and ...

AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks ...

and that shift is reflected in the list of the top 15 drugs by total spend for Vizient pharmacy program participants. Humira®, manufactured by AbbVie, is again at the top of the list and semaglutide ...